Éric Lefebvre

机构：Université Paris Cité, CEA DAM Île-de-France, Health and Functional Exposomics, Pliant (United States), University of San Francisco · ORCID：0009-0008-0587-8265

发表论文 232 篇 · 总被引 9757 次 · h-index 46

代表论文

• Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis: The INTEGRIS-IPF Clinical Trial (2024 · American Journal of Respiratory and Critical Care Medicine · 被引 71)
• Dual αvβ6 and αvβ1 Inhibition over 12 Weeks Reduces Active Type I Collagen Deposition in Individuals with Idiopathic Pulmonary Fibrosis: A Phase 2, Double-Blind, Placebo-controlled Clinical Trial (2025 · American Journal of Respiratory and Critical Care Medicine · 被引 22)
• First indirect drive inertial confinement fusion campaign at Laser Megajoule (2023 · Physics of Plasmas · 被引 20)
• Bexotegrast Shows Dose-Dependent Integrin αvβ6 Receptor Occupancy in Lungs of Participants with Idiopathic Pulmonary Fibrosis: A Phase 2, Open-Label Clinical Trial (2024 · Annals of the American Thoracic Society · 被引 13)
• Experimental capabilities of the LMJ-PETAL facility (2024 · High Energy Density Physics · 被引 11)
• Phase II INTEGRIS-PSC trial of bexotegrast, an αvβ6/αvβ1 integrin inhibitor, in primary sclerosing cholangitis (2025 · Journal of Hepatology · 被引 9)